Posters
AKI: Biomarkers, Diagnostics, and Risk Prediction
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Dickkopf-3, a Key Driver of Renal Fibrosis, Is Increased in the Urine of Patients with Tubulointerstitial Nephritis
Urinary Amphiregulin Reflects Tubular Injury Severity in Patients with AKI
Higher Urine Neutrophil Gelatinase-Associated Lipocalin Threshold Optimizes Prediction of New or Persistent Severe AKI in Children with Septic Shock
Predictive Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecular-1 (KIM-1), Cystatin C, and TIMP-2 IGFBP7 for Cardiopulmonary Bypass-Associated AKI: A Systematic Review and Meta-Analysis
Three-Metabolite Admission Signature Predicts Severe AKI in Patients in the Intensive Care Unit (ICU): Beyond Sequential Organ Failure Assessment (SOFA) and Neutrophil Gelatinase-Associated Lipocalin (NGAL)
Overcoming the Creatinine Lag: Superior Predictive Power of 12-Hour Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecular-1 (KIM-1), and IL-18 for AKI After Coronary Artery Bypass Grafting
Longitudinal Plasma and Urinary Biomarkers for Predicting Acute Kidney Disease in Patients with Sepsis-Associated AKI: A Prospective Cohort Study
Plasma Complement Factor Ba Is Elevated in Critically Ill Children with Sepsis-Associated AKI
Monocyte Imbalance Predicts AKI After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
Guanidinoacetate and Creatine: A Potential Novel Marker in AKI
Combining a Multimodal Deep Learning Risk Model with Biomarkers to Identify Patients at High Risk
Dynamic Prediction of AKI Reversal in Critically Ill Patients Using a Transformer-Based Artificial Intelligence (AI) Model
Risk Prediction Model for Development of CKD After AKI in Pediatric Patients
Development of a Nomogram for Predicting Kidney Replacement Therapy and Hyperkalemia in AKI
Effect of Hemoglobin Increase on Major Adverse Kidney Events in Patients with AKI and Severe Anemia
AKI and Major Adverse Kidney Events During Colistin Therapy: Clinical Predictors and Prognostic Implications
Early Physical Rehabilitation Restores the Prognostic Utility of Creatinine in AKI
AKI Risk Stratification, Dialysis Risk, and Nephrology Consultation: A 20-Year Cohort Study
Should We Eliminate KDIGO Stage 2 from AKI Classification?
Administrative Severity Discordance in AKI
Higher Mortality with Less Care in AKI
Diagnostic Reclassification of Volume Status Using Point-of-Care Ultrasonography and Venous Excess Ultrasound in Hospitalized Patients with AKI
Correlation of Urinary Electrolyte Excretion Fractions with AKI Severity in Patients in the Intensive Care Unit
Discrepancy Between Serum Creatinine and Serum Cystatin C in Precipitous AKI Due to Vancomycin
Contrast-Induced Nephropathy: A Prospective Comparative Study Using Capillary Blood Sampling with Point-of-Care Creatinine Measurement
Effect of Atherogenic Index of Plasma on Risk of Contrast-induced AKI: An In-Hospital Electronic Monitoring System
Clinical Phenotyping of Vancomycin-Associated Kidney Injury Using Large Electronic Health Data
Clinical Phenotyping of Tacrolimus-Associated Kidney Injury Using Large Electronic Health Data
Clinical Phenotyping of Drug-Induced Kidney Injury Using Large Electronic Health Data
Clinical Phenotyping of Nonsteroidal Anti-Inflammatory Drug-Associated Kidney Injury Using Large Electronic Health Data
Effect of Finerenone on Kidney Outcomes in Malignant Hypertension-Associated Kidney Injury: A Propensity Score-Matched Retrospective Cohort Study
Renal Safety of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH): Findings from Clinical Trials and Global Real-World Experience
An Unusual Discordance Between Cystatin C and Serum Creatinine in a Patient with Postrenal AKI
Monoclonal IgM-Associated Pseudohypercreatininemia Mimicking Rapidly Progressive Kidney Dysfunction After COVID-19
Role of Cystatin C-Based eGFR in Integrase Strand Transfer Inhibitor-Associated Elevation in Serum Creatinine
Alterations in Bone and Mineral Metabolism in AKI: A Scoping Review and Evidence Map
Ulinastatin and AKI: Is It the Answer We Are Looking For?
Renal Hemosiderosis as a Distinct Clinicopathologic Entity: An International Multicenter Study of Etiology, Histologic Patterns, and Kidney Outcomes
Kidney Biopsy in Patients with Diabetes, AKI, and Heavy Proteinuria
Prognostic Value of ANCA Kidney Risk Score for Kidney Outcomes in ANCA-Associated Vasculitis: A Retrospective Study
Sex Differences in Outcomes and Care Processes After Outpatient AKI
Nephrologist Follow-Up Reduces Recurrent AKI in AKI Survivors: A Propensity Score-Matched Study
TRACK-AKI: Quality and Predictors of Guideline-Concordant Transitions of Care After AKI
Early Implementation Experience with AKI Communication Guides
Clinical Outcomes of Isuzinaxib Across the AKI-to-AKD Continuum: Redefining Clinically Meaningful Kidney End Points
Patient-Reported Outcomes by Dialysis Weaning Strategy in Dialysis-Requiring AKI